跳至主要内容
临床试验/ISRCTN86192648
ISRCTN86192648已完成3 期

Trial of the effectiveness and cost effectiveness of selfmonitoring and treatment of blood pressure in secondary prevention following stroke or transient ischaemic attack

orfolk and Norwich University Hospital NHS Trust0 个研究点目标入组 156 人开始时间: 2015年6月10日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
156

研究概览

简要总结

  1. 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30060882 (added 23/01/2019) 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30415084 (added 23/01/2019) 3. 2020 economic evaluation in https://www.ncbi.nlm.nih.gov/pubmed/32056146 (added 17/02/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age >= 55 years
  • 2. Patients with TIA or stroke of mild/moderate severity (NIHSS =<15)
  • 3. Patients that require BP management
  • 4. Patients able and willing to undertake self BP measurement and guided alterations in therapy

排除标准

  • 1. Patients with terminal illness with life expectancy less than six months including end staged condition e.g. end stage COPD Dementia
  • 2. Patients with moderate to severe cognitive impairment
  • 3. Patients not receiving or expected to start antihypertensive therapy

研究者

发起方
orfolk and Norwich University Hospital NHS Trust

相似试验

Effectiveness and cost effectiveness of... | 临床试验